Home
Natco Pharma Ltd 52 Week Low

Natco Pharma Ltd
NSE: NATCOPHARM
YEARLOW
Key Highlights
- The 52 Week Low of Natco Pharma Ltd is ₹ 777.3 as of 21 Feb 25 .
Company Fundamentals for Natco Pharma Ltd
Market Price of Natco Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 797.75 |
20 Feb 2025 | 793 |
19 Feb 2025 | 812.55 |
18 Feb 2025 | 834.6 |
17 Feb 2025 | 870.15 |
14 Feb 2025 | 883.7 |
13 Feb 2025 | 973.4 |
12 Feb 2025 | 1216.65 |
11 Feb 2025 | 1241.15 |
10 Feb 2025 | 1280.1 |
Asset Value vs Market Value of Natco Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Natco Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Natco Pharma Ltd
Historical Net Profit of Natco Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Natco Pharma Ltd
Natco Pharma Ltd News Hub
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad
Read more
04 Sept 24
Natco Pharma fixes record date for second interim dividend
Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The
Read more
12 Aug 24
Board of Natco Pharma recommends dividend
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2
Read more
12 Aug 24
Natco Pharma schedules AGM
Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30
Read more
12 Aug 24